Wegovy 0.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRSV3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,253
Award facts
- Contract value 100% obligated
- $11,253.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,253.03 delivery order to AmerisourceBergen Drug Corp for Wegovy 0.5 mg/0.5 mL pen injectors, with an ultimate completion date of August 19, 2025. This is a firm fixed price contract with no set-aside designation, awarded competitively on August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The SPE2DX prime contract enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other medical commodities. This specific delivery order for Wegovy, a GLP-1 receptor agonist used for weight management, reflects the company's role in supplying specialized pharmaceutical treatments to defense healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FRSV3?
SPE2DB25FRSV3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FRSV3 worth?
The government has obligated $11,253 on SPE2DB25FRSV3.
Is contract SPE2DB25FRSV3 an order under another contract?
Yes. SPE2DB25FRSV3 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRSV3 competed?
The extent of competition for SPE2DB25FRSV3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award